Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Aarti Dureja
Institution:
University of Colorado Cancer Center
Observed institution:
University of Colorado Cancer Center
ORCID:
0000-0002-9375-2476
Observed ORCID:
0000-0002-9375-2476
OpenAlex ID:
A5152497593
Figure 3 from Dissociated Response to Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma Is Common and Exhibits Distinct Clinical Outcomes
2026
·
Alice N. Weaver
, Stephen B. Keysar
, et al.
Supplemental Figure 3 from Dissociated Response to Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma Is Common and Exhibits Distinct Clinical Outcomes
2026
·
Alice N. Weaver
, Stephen B. Keysar
, et al.
Supplemental Figure 1 from Dissociated Response to Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma Is Common and Exhibits Distinct Clinical Outcomes
2026
·
Alice N. Weaver
, Stephen B. Keysar
, et al.
Table 1 from Dissociated Response to Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma Is Common and Exhibits Distinct Clinical Outcomes
2026
·
Alice N. Weaver
, Stephen B. Keysar
, et al.
Data from Dissociated Response to Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma Is Common and Exhibits Distinct Clinical Outcomes
2026
·
Alice N. Weaver
, Stephen B. Keysar
, et al.
Figure 2 from Dissociated Response to Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma Is Common and Exhibits Distinct Clinical Outcomes
2026
·
Alice N. Weaver
, Stephen B. Keysar
, et al.
Figure 1 from Dissociated Response to Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma Is Common and Exhibits Distinct Clinical Outcomes
2026
·
Alice N. Weaver
, Stephen B. Keysar
, et al.
Figure 4 from Dissociated Response to Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma Is Common and Exhibits Distinct Clinical Outcomes
2026
·
Alice N. Weaver
, Stephen B. Keysar
, et al.
Supplemental Table 2 from Dissociated Response to Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma Is Common and Exhibits Distinct Clinical Outcomes
2026
·
Alice N. Weaver
, Stephen B. Keysar
, et al.
Supplemental Table 1 from Dissociated Response to Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma Is Common and Exhibits Distinct Clinical Outcomes
2026
·
Alice N. Weaver
, Stephen B. Keysar
, et al.
Supplemental Figure 2 from Dissociated Response to Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma Is Common and Exhibits Distinct Clinical Outcomes
2026
·
Alice N. Weaver
, Stephen B. Keysar
, et al.
Table 2 from Dissociated Response to Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma Is Common and Exhibits Distinct Clinical Outcomes
2026
·
Alice N. Weaver
, Stephen B. Keysar
, et al.
Dissociated Response to Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma Is Common and Exhibits Distinct Clinical Outcomes
2026
·
Alice N. Weaver
, Stephen B. Keysar
, et al.
·
Cancer Research Communications
Show more works
View as search
Works count:
13
Citation count:
H-index:
I10-index:
Year
Topic
Type